|
SLTM expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.942700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.163600E-02 |
| Normal-vs-Stage2 |
8.059900E-02 |
| Normal-vs-Stage3 |
5.91309999999901E-05 |
| Normal-vs-Stage4 |
3.964100E-04 |
| Stage1-vs-Stage2 |
4.924200E-01 |
| Stage1-vs-Stage3 |
1.581410E-03 |
| Stage1-vs-Stage4 |
1.037520E-02 |
| Stage2-vs-Stage3 |
1.842620E-01 |
| Stage2-vs-Stage4 |
2.473200E-01 |
| Stage3-vs-Stage4 |
8.668400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.847400E-04 |
| Normal-vs-AfricanAmerican |
4.706000E-01 |
| Normal-vs-Asian |
4.908400E-01 |
| Caucasian-vs-AfricanAmerican |
4.100300E-02 |
| Caucasian-vs-Asian |
5.076400E-02 |
| AfricanAmerican-vs-Asian |
3.237800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.378800E-04 |
| Normal-vs-Female |
1.443640E-01 |
| Male-vs-Female |
2.435300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.184330E-02 |
| Normal-vs-Age(41-60Yrs) |
2.049700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.081300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.706400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.911810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.360200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.481000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.884600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.372200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.288200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.650370E-01 |
| Normal-vs-Grade 2 |
1.496640E-01 |
| Normal-vs-Grade 3 |
1.410470E-04 |
| Normal-vs-Grade 4 |
1.78527999999956E-05 |
| Grade 1-vs-Grade 2 |
3.257800E-02 |
| Grade 1-vs-Grade 3 |
3.810100E-04 |
| Grade 1-vs-Grade 4 |
2.09439999999672E-05 |
| Grade 2-vs-Grade 3 |
1.795710E-03 |
| Grade 2-vs-Grade 4 |
7.52950000000308E-05 |
| Grade 3-vs-Grade 4 |
1.268990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.976600E-01 |
| Normal-vs-ccB subtype |
9.60890000012427E-07 |
| ccA subtype-vs-ccB subtype |
1.57609999495989E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.057400E-03 |
| Normal-vs-N1 |
2.228000E-02 |
| N0-vs-N1 |
3.876600E-01 |
|
|
